REFERENCES
- D. R Brocks, S Ala, and H. M. Aliabadi. (2006). The effect of increased lipoprotein levels on the pharmacokinetics of cyclosporine A in the laboratory rat. Biopharm. Drug Dispos. 27:7–16.
- W. N Charman, and V. J. Stella. (1991). Transport of lipophilic molecules by the intestinal lymphatic system. Adv. Drug Deliv. Rev. 7:1–14.
- J. Eccleston. (1994). Encyclopedia of Pharmaceutical Technology. New York: Marcel Dekker.
- F. Y. Gao. (2003). Advances of pharmacological effects of Puerarin. Chin. Tradit. Herb Drug 34:7–8.
- T Gershanik, and S. Benita. (2000). Self-dispersing lipid formulations for improving oral absorption of lipophilic drugs. Eur. J. Pharm. Biopharm. 50:179–188.
- P Gershkovich, D Shtainer, and A. Hoffman. (2007). The effect of a high-fat meal on the pharmacodynamics of a model lipophilic compound that binds extensively to triglyceride-rich lipoproteins. Int. J. Pharm. 333:1–4.
- A. J Humberstone, and W. N. Charman. (1997). Lipid-based vehicles for the oral delivery of poorly water soluble drugs. Adv. Drug Deliv. Rev. 25:103–128.
- X. L Jin, G. F Cheng, and X. Y. Zhu. (1991). Pharmacokinetics of Puerarin in Voluteers. China J. Clin. Pharmacol. 7:115–118.
- M. J Lawrence, and G. D. Rees. (2000). Microemulsion-based media as novel drug delivery systems. Adv. Drug Deliv. Rev. 45:89–121.
- Y Li, W. S Pan, S. L Chen, D. J Yang, X. Z Chen, and H. X. Xu. (2006). Studies on preparation of Puerarin phytosomes and their solid dispersions. Chin. Pham. J. 41:1162–1167.
- P. D Lundin, M Bojrup, H Ljusberg-Wahren, B. R Westrom, and S. Lundin. (1997). Enhancing effects of monohexanoin and two other medium-chain glyceride vehicles onintestinal absorption of desmopressin (dDAVP). Pharmcol. Exp. Ther. 282:585–590.
- T Lindmark, N Schipper, L Lazorova, A. G de Boer, and P. Artursson. (1998). Absorption enhancement in intestinal epithelial Caco-2 monolayers by sodium caprate: Assessment of molecular weight dependence and demonstration of transport routes. Drug Target. 5:215–223.
- J. M. Moulik, and B. K. Paul. (1998). Structure, dynamics and transport properties of microemulsion. Adv. Colloid Interface Sci. 78:99–195.
- C. M. O'Driscoll. (2002). Lipid-based formulations for intestinal lymphatic delivery. Eur. J. Pharm. Sci. 15:405–415.
- J. R. Robinson. (1978). Sustained and controlled release drug delivery systems ( pp. 71–121). New York: Marcel Dekker.
- E. S Swenson, and W. J. Curatolo. (1992). Means to enhance penetration. Adv. Drug Deliv. Rev. 8:39–42.
- A Shayeganpour, A. S Jun, and D. R. Brocks. (2005). Pharmacokinetics of Amiodarone in hyperlipidemic and simulated high fat-meal rat models. Biopharm. Drug Dispos. 26:249–257.
- M. J Schwuger, and K. Stickdorn. (1995). Microemulsion in technical processes. Chem. Rev. 95:849–864.
- R. L Shi, and J. J. Zhang. (2003). Protective effect of Puerarin on vascular endothelial cell apoptosis induced by chemical hypoxia in vitro. Acta Pharm. Sin. 38:103–107.
- Z. S Tang, D. Y Guo, and Y. Rong. (2005). Bioavailability investigation of Pur-powder and micro-powder in Beagle dogs. Liaoning Tradit. Chin. Med. 32:830–831.
- Z Wang, C. Y Yang, L. F Lu, and J. B. Zhu. (1997). Studies on absorptive mechanism of Insulin in oral microemulsion. J. Chin. Pharm. Uni. 28:23–325.
- A Yamamoto, T Okagawa, and A. Kotani. (1997). Effects of different absorption enhancers on the permeation of ebiratide, an ACTH analogue, across intestinal membranes. Pharm. Pharmacol. 49:1057–1061.
- Z. R Zhang, X. J You, Z. P Wei, Q He, and Z. W. Li. (1997). Pharmacokinetics and bioavailability of Yufeng Ningxin tablet in rabbits[J]. Chin. Pharm. J. 32:224–226.
- X. Y. Zhu. (1979). Pharmacokinetics of Puerarin. Acta Pharm. Sin. 17:349.
- Y. S Zhou, Y. Y Jia, X. Q Shen, X. C Zhu, S Gao, and A. L. Wu. (2003). Studies on preparation and in vitro evaluation of Puerarin solid dispersions. Chin. Pharm. 38:42–44.